Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | MGLL | Q99685 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Salicyl Alcohol SCHEMBL27722016 | 0.90 | TDP1 (0.43) | TDP1ALDH1A1GLATSHRSMN1; SMN2 | |
| SCHEMBL733081 | 0.83 | TDP1 (0.41) | TDP1ALDH1A1GLATSHRSMN1; SMN2 | |
| Benzyl Alcohol SCHEMBL14889734 | 0.83 | TSHR (0.52) | TDP1ALDH1A1GLATSHRSMN1; SMN2 | |
| SCHEMBL8660205 | 0.82 | TDP1 (0.50) | TDP1ALDH1A1GLATSHRSMN1; SMN2 | |
| SCHEMBL4275811 | 0.82 | ALDH1A1 (0.42) | TDP1ALDH1A1GLATSHRSMN1; SMN2 | |
| SCHEMBL1715056 | 0.81 | TDP1 (0.48) | TDP1ALDH1A1GLATSHRSMN1; SMN2 | |
| SCHEMBL2301121 | 0.80 | HSPA5 (0.55) | TDP1ALDH1A1GLATSHRSMN1; SMN2 | |
| SCHEMBL1140449 | 0.80 | ALDH1A1 (0.62) | TDP1ALDH1A1GLATSHRSMN1; SMN2 | |
| SCHEMBL732958 | 0.80 | TDP1 (0.52) | TDP1ALDH1A1GLATSHRSMN1; SMN2 | |
| Catechol SCHEMBL679936 | 0.80 | TDP1 (0.52) | TDP1ALDH1A1GLATSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114525072-A | Polyethers containing cyclic groups other than bisphenols | 宣伟投资管理有限公司 | 2022-05-24 | — | — | CN | claimed |
| CN-104039862-A | Sulfide-extended epoxy resin and application of barrier coating thereof | SUN CHEMICAL CORP | 2014-09-10 | — | — | CN | claimed |
| US-20240239954-A1 | POLYESTER COPOLYMER AND COATING COMPOSITIONS THEREFROM HAVING IMPROVED CORROSION RESISTANCE | SWIMC LLC (US) | 2024-07-18 | — | — | US | disclosed |
| EP-4347733-A1 | POLYESTER COPOLYMER AND COATING COMPOSITIONS THEREFROM HAVING IMPROVED CORROSION RESISTANCE | Swimc LLC (US) | 2024-04-10 | — | — | EP | disclosed |
| WO-2022251858-A1 | POLYESTER COPOLYMER AND COATING COMPOSITIONS THEREFROM HAVING IMPROVED CORROSION RESISTANCE | SWIMC LLC (US) | 2022-12-01 | — | — | WO | disclosed |
| CN-114525072-A | Polyethers containing cyclic groups other than bisphenols | 宣伟投资管理有限公司 | 2022-05-24 | — | — | CN | disclosed |
| US-20200317953-A1 | POLYETHERS CONTAINING NON-BISPHENOLIC CYCLIC GROUPS | SWIMC LLC (US) | 2020-10-08 | — | — | US | disclosed |
| US-10793742-B2 | Polyethers containing non-bisphenolic cyclic groups | VALSPAR SOURCING, INC. (US) | 2020-10-06 | — | — | US | disclosed |
| EP-2788398-B1 | SULFIDE EXTENDED EPOXY RESINS AND BARRIER COATINGS APPLICATIONS THEREOF | SUN CHEMICAL CORP (US) | 2018-07-25 | — | — | EP | disclosed |
| US-9624380-B2 | Sulfide extended epoxy resins and barrier coating applications thereof | SUN CHEMICAL CORPORATION (US) | 2017-04-18 | — | — | US | disclosed |
| EP-3146009-A1 | POLYETHERS CONTAINING NON-BISPHENOLIC CYCLIC GROUPS | Valspar Sourcing, Inc. (US) | 2017-03-29 | — | — | EP | disclosed |
| US-8138278-B2 | Polymer compositions and methods of making and using same | POLYMERIGHT, INC. (US) | 2012-03-20 | — | — | US | disclosed |
| US-20110152492-A1 | Polymer Compositions and Methods of Making and Using Same | POLYMERIGHT, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| US-7910666-B2 | Mercaptan-hardened epoxy polymer compositions and processes for making and using same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2011-03-22 | — | — | US | disclosed |
| WO-2011008480-A1 | POLYMER COMPOSITIONS AND METHODS OF MAKING AND USING SAME | POLYMERIGHT, INC. (US) | 2011-01-20 | — | — | WO | disclosed |
| WO-2009132010-A1 | METHODS AND SYSTEMS FOR MAKING THIOL COMPOUNDS FROM TERMINAL OLEFINIC COMPOUNDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2009-10-29 | — | — | WO | disclosed |
| US-20090264669-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2009-10-22 | — | — | US | disclosed |
| EP-1940992-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | Chevron Phillips Chemical Company LP (US) | 2008-07-09 | — | — | EP | disclosed |
| US-20070112100-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY, LP | 2007-05-17 | — | — | US | disclosed |
| WO-2007022217-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2007-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264669-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | TST, HHAT, GSTO1 | TDP1 2381/4885ALDH1A1 157/4885GLA 2787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.